Predefined health economic secondary analysis of an RCT in 426 patients with non-palpable breast cancer: magnetic seed vs guidewire localisation costs did not differ unadjusted (−€63, P=0.599) but were €391 (11.1%) lower after adjustment.
Secondary analysisn = 426
Pantiora et al. Magnetic seed versus guidewire-based breast cancer localization with magnetic lymph node detection: cost-minimization analysis